Missing inaction: Preventing missing outcome data in randomized clinical trials

Journal of Biopharmaceutical Statistics

Volumn 19, Issue 6, 2009, Pages 957-968

  Wittes, Janet ^a  

^a University of Iowa   (United States)

Author keywords

Completers analysis; Imputation; Last observation carried forward; Missing data; Multiple imputation; Randomized clinical trials

Indexed keywords

DIMEBON; SEROTONIN 2C AGONIST; THALIDOMIDE;

ALZHEIMER DISEASE; CASE REPORT; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL; DATA ANALYSIS; HUMAN; INFORMED CONSENT; METHODOLOGY; OBESITY; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS; WASTING SYNDROME;

DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; FOLLOW-UP STUDIES; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 75749136125     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903239825     Document Type: Review

References (18)

1. Bezjak, A. B., Lee, C. W., Ding, K. (2008). Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: Results from a randomized trial. J. Clin. Oncol. 26:5052-5059.
2. Coronary Drug Project Research Group. (1980). Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N. Engl. J. Med. 303:1038-1041.
3. Di Bisceglie, A. M., Shiffman, M. L., Everson, G. T., Lindsay, K. L., Everhart, J. E., Wright, E. C., Lee, W. M., Lok, A. S. Bonkovsky, H. L., Morgan, T. R., Ghany, M. G., Morishima, C., Show, K. K., Dienstag, J. L. (2008). Therapy of advanced chronic hepatitis C with low-dose peginterferon. N. Engl. J. Med. 359:2429-2441.
4. Doody, R. S., Gavrilova, S. I., Sano, M., Thomas, R. G., Aisen, P. S., Bachurin, S. O., Seely, L., Hung, D. (2008). Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: A randomised, double-blind, placebo-controlled study. Lancet 372(9634):207-215.
5. Food and Drug Administration. (2005). Guidance for Industry: Acne Vulgaris: Developing Drugs of Treatment. Washington, DC: U.S. Department of Health and Human Services.
6. Good Clinical Practice Program. (2008). Guidance for Sponsors, Clinical Investigators, and IRBs: Data Retention When Subjects Withdraw from FDA-Regulated Clinical Trials. Washington, DC: U.S. Department of Health and Human Services.
7. Jenkins, J. A., Kendall, C. W. C., McKeown-Eyssen, G., Josse, R. G., Silverberg, J., Booth, G. L., Vidgen, E., Josse, A. R., Nguyen, T. H., Corrigan, S., Banach, M. S., Ares, S., Mitchell, S., Emam, A., Augustin, L. S., Parker, T. L., Leiter, L. A. (2008). Effect of a low-glycemic index or a high-cereal fiber diet on Type 2 diabetes. J. Am. Med. Assoc. 300:2742-2753.
8. Kaplan, G., Thomas, S., Fierer, D. S., Mulligan, K., Haslett, P. A., Fessel, W. J., Smith, L. G., Kook, K. A., Stirling, D., Schambelan, M. (2000). Thalidomide for the treatment of AIDS-associated wasting. AIDS Res. Hum. Retroviruses. 16:1345-1355.
9. Kim, Y. (2007). Chronic pain trials and missing data. FDA/Industry Workshop. www.amstat.org/meetings/fdaworkshop
10. Land, S. (2008). Missing patient-reported outcome data in an adjuvant lung cancer study. J. Clin. Oncol. 26:5018-5019.
11. O'Brien, P. C., Zhang, D., Bailey, K. R. (2005). Semi-parametric and non-parametric methods for clinical trials with incomplete data. Stat. Med. 24:341-358.
12. ONTARGET Investigators. (2008). Telmisartan, ramipril, or both in patients at high risk for vascular events. N. Engl. J. Med. 358:1547-1559.
13. Permutt, T. (2008). Continuous outcomes and dichotomies are both approximations. FDA/Industry Workshop. www.amstat.org/meetings/fdaworkshop
14. Pfeffer, M. A., McMurray, J. J. V., Velazquez, E. J., Rouleau, J. L., Kober, L., Maggioni, A. P., Solomon, S. D., Swedberg, K., Van de Werf, F., White, H., Leimberger, J. D., Henis, M., Edwards, S., Zelenkofske, S., Sellers, M. A., Califf, R. M. (2003). Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N. Engl. J. Med. 349:1893-1906. (Pubitemid 37409706)
15. Proschan, M., McMahon, R, Shih, J., Hunsberger, S. A., Geller, N. L., Knatterud, G., Wittes, J. (2001). Sensitivity analysis using an imputation method for missing binary data in clinical trials. J. Stat. Plan. Inference 96:155-165.
16. Rubin, D. R. (1987). Multiple Imputation for Non Response in Surveys. New York: John Wiley and Sons.
17. SAS Institute, Inc. (2006). SAS/IML User's Guide. Version 9. Cary, NC: SAS Institute, Inc.
18. Smith, S. R., Prosser, W. A., Donahue, D. J., Morgan, M. E., Anderson, C. M., Shanahan, W. R. (2008). Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women. Obesity 17:494-503.